Industry News

Industry News

Advanced Prostate Cancer Drug Xofigo Approved By FDA

May 17, 2013

Xofigo (radium Ra 223 dichloride) has been approved by the US FDA for symptomatic late-stage (metastatic) castration-resistant prostate cancer that has reached bones but not other organs, i.e. with no known visceral metastatic disease. The Food and Drug Administration (FDA) approved Xifogo under the priority review program, three months ahead of schedule... Read More

Researchers Discover Master Regulator That Drives Majority Of Lymphoma

May 17, 2013

New Findings Show Inhibiting Powerful Protein with New Agents May Supply Broad Benefit for Lymphoma Patients A soon-to-be-tested class of drug inhibitors were predicted to help a limited number of patients with B-cell lymphomas with mutations affecting the EZH2 protein... Read More

Skin Cancer Link To Lower Risk Of Alzheimer's Disease, Says Study

May 17, 2013

People who have skin cancer may be less likely to develop Alzheimer's disease, according to research published this week in Neurology®. Researchers at the Albert Einstein College of Medicine in New York, followed 1,102 people who did not have dementia. They had an average age of 79 and were followed for an average of 3.7 years. 109 people reported that they had skin cancer in the past... Read More

Study Suggests Cutaneous Squamous Cell Carcinoma Carries Risk Of Metastasis And Death

May 17, 2013

JAMA Dermatology Study Highlights A study by Chrysalyne D. Schmults, M.D., M.S.C.E., of Brigham and Women's Hospital, Boston, and colleagues suggests cutaneous squamous cell carcinoma (CSCC) carries a low but significant risk of metastasis and death. The ten-year retrospective cohort study was conducted at an academic medical center in Boston, and included 985 patients with 1,832 tumors... Read More

Hot On The TRAIL Of Graft Vs. Host Disease

May 17, 2013

For patients with leukemia and other hematological malignancies, transplantation of hematopoietic stem cells (HSCT) can be a powerfully effective therapy. In addition to the desirable anti-tumor effect, transplanted cells can also attack the host tissue, resulting in graft-versus-host disease (GVHD)... Read More

Data Addressing Patient And Physician Barriers To Clinical Trials To Be Presented By Experts

May 17, 2013

Researchers from University Hospitals Case Medical Center's (UHCMC) Seidman Cancer Center in Cleveland, OH, will present findings from two studies evaluating new technologies designed to address common barriers to patient enrollment in clinical trials... Read More

Women In 40s Continue To Get Routine Mammograms At Same Rate, Despite New Recommendations

May 17, 2013

Women in their 40s continue to undergo routine breast cancer screenings despite national guidelines recommending otherwise, according to new Johns Hopkins research. In 2009, the U.S... Read More

Early Stage Testicular Cancer - Surveillance Is Best Follow-Up Strategy

May 17, 2013

A long-term study of men with stage I seminoma, a common form of testicular cancer, suggests that surveillance for cancer recurrence, rather than additional chemotherapy or radiation therapy, is sufficient for the vast majority of patients who have undergone successful surgery for their cancer... Read More

Comorbidities Taken Into Account Before Prostate Biopsy

May 17, 2013

UC Irvine Health urologists and health policy experts report in a new study that two written assessments that identify existing comorbidities - the patient-reported Total Illness Burden Index for Prostate Cancer (TIBI-Cap) and the physician-reported Charlson Comorbidity Index - can successfully target prostate patients who would not benefit from biopsy to discover possible cancer... Read More

Study Explores Providers' Perceptions Of Parental Concerns About HPV Vaccination

May 17, 2013

A new Boston University School of Medicine (BUSM) study has found that low-income and minority parents may be more receptive to vaccinating their daughters against Human Papillomavirus (HPV), while white, middle-class parents are more likely to defer the vaccination. The findings appear online in the May issue of the Journal of Health Care for the Poor and Underserved... Read More

Previous Page   Next Page